Small trial probes arthritis drug for stubborn lupus skin symptoms
NCT ID NCT03288324
Summary
This study tested if a drug called tofacitinib, which is used for arthritis, could help control moderate to severe skin rashes caused by lupus. It involved 13 young adults and primarily aimed to see if the drug was safe and how it behaved in their bodies over 76 weeks. The researchers also looked for early signs that it might improve the skin rash.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
Conditions
Explore the condition pages connected to this study.